Tunable Isotropic TPMS-Based 3D-Architected Scaffolds for Diabetic Bone Regeneration
- Fátima Morales-Gómez,
- ,
- ,
- Erick Ramírez-Cedillo,
- Josué García-Ávila(corresponding author)
- Universidad Anáhuac Querétaro,
- ,
- ,
- ,
- ,
- Instituto Tecnologico de Estudios Superiores de Monterrey
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 278-285 (8 pages)Publication milestones
- Published - 01/01/2025
Publication status
Publisher
Springer Science and Business Media Deutschland GmbHPublication series
- Publication series name: IFMBE Proceedings
ISSN (Print): 1680-0737
ISSN (Electronic): 1433-9277
Volume: 131
ISBN (Print)
9783031965371Publication IDs
- Scopus: 105010211545
Host publication title
Joint 20th Nordic-Baltic Conference on Biomedical Engineering and 24th Polish Conference on Biocybernetics and Biomedical Engineering - Joint Proceedings of NBC 2025 and PCBBE 2025Host publication editors
- Piotr Ladyzynski
- Dorota G. Pijanowska
- Adam Liebert
Abstract
Diabetes mellitus significantly compromises bone health, increasing the risk of fractures, osteoporosis, and limb amputations due to metabolic dysfunctions. Effective bone regeneration is critical for managing complex fractures and bone-related complications, with over two million bone grafts performed annually. This research focuses on designing and developing personalized 3D-architected scaffolds to enhance bone regeneration in patients with diabetes using computational simulation techniques. These scaffolds are tailored to replicate the mechanical and structural properties of natural bone by optimizing key features such as anisotropy, porosity, and nutrient mass flow. The study highlights the transformative potential of personalized 3D-architected scaffolds in addressing critical challenges associated with diabetic bone health. Customizing scaffold designs to meet the specific needs of patients with diabetes aims to reduce postoperative complications, improve healing outcomes, and enhance overall patient quality of life. Future work will refine scaffold designs and validate their performance in diabetes-specific clinical in vitro and in vivo models.
